Moderna Inc (ticker MRNA; NASDAQ) is a biotech company headquartered in Cambridge, MA (USA).
The company is primarily involved in the development of "matrix-DNA" treatments for cancers and severe cardiovascular, metabolic and renal diseases.
The company was initially established in 2010 under the name "ModeRNA".
The co-founder and CEO of Moderna Inc, which employs 760 people, is Armenian-American entrepreneur Nubar Afeyan.
In 2019, the company recorded more than $60 million in turnover.
Shares and listings
The company's shares are traded on the NASDAQ and are weighted in the NASDAQ Composite index. The company has 368.643M shares outstanding, with capitalisation of over $8B.